Detalhe da pesquisa
1.
Epigenetic alterations in glioblastomas: Diagnostic, prognostic and therapeutic relevance.
Int J Cancer
; 153(3): 476-488, 2023 Aug 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-36479695
2.
Microsatellite Instability: From the Implementation of the Detection to a Prognostic and Predictive Role in Cancers.
Int J Mol Sci
; 23(15)2022 Aug 05.
Artigo
em Inglês
| MEDLINE | ID: mdl-35955855
3.
KEYNOTE-921: Phase III study of pembrolizumab plus docetaxel for metastatic castration-resistant prostate cancer.
Future Oncol
; 17(25): 3291-3299, 2021 Sep.
Artigo
em Inglês
| MEDLINE | ID: mdl-34098744
4.
Sequencing radium 223 and other life-prolonging agents in castration-resistant prostate cancer patients.
Future Oncol
; 17(7): 807-815, 2021 Mar.
Artigo
em Inglês
| MEDLINE | ID: mdl-33508980
5.
Quality of life in patients with metastatic prostate cancer following treatment with cabazitaxel versus abiraterone or enzalutamide (CARD): an analysis of a randomised, multicentre, open-label, phase 4 study.
Lancet Oncol
; 21(11): 1513-1525, 2020 11.
Artigo
em Inglês
| MEDLINE | ID: mdl-32926841
6.
Fracture risk and survival outcomes in metastatic castration-resistant prostate cancer patients sequentially treated with abiraterone acetate and RADIUM-223.
Eur J Nucl Med Mol Imaging
; 47(11): 2633-2638, 2020 10.
Artigo
em Inglês
| MEDLINE | ID: mdl-32249345
7.
Resveratrol in Cancer Patients: From Bench to Bedside.
Int J Mol Sci
; 21(8)2020 Apr 22.
Artigo
em Inglês
| MEDLINE | ID: mdl-32331450
8.
Second line therapy with axitinib after only prior sunitinib in metastatic renal cell cancer: Italian multicenter real world SAX study final results.
J Transl Med
; 17(1): 296, 2019 08 29.
Artigo
em Inglês
| MEDLINE | ID: mdl-31464635
9.
Abiraterone acetate treatment in patients with castration-resistant prostate cancer with visceral metastases: a real-world experience.
Anticancer Drugs
; 30(2): 179-185, 2019 02.
Artigo
em Inglês
| MEDLINE | ID: mdl-30320608
10.
Activity and safety of metronomic cyclophosphamide in the modern era of metastatic castration-resistant prostate cancer.
Future Oncol
; 15(10): 1115-1123, 2019 04.
Artigo
em Inglês
| MEDLINE | ID: mdl-30887825
11.
Patient-reported outcomes following abiraterone acetate plus prednisone added to androgen deprivation therapy in patients with newly diagnosed metastatic castration-naive prostate cancer (LATITUDE): an international, randomised phase 3 trial.
Lancet Oncol
; 19(2): 194-206, 2018 02.
Artigo
em Inglês
| MEDLINE | ID: mdl-29326030
12.
Proanthocyanidins and the risk of prostate cancer in Italy.
Cancer Causes Control
; 29(2): 261-268, 2018 02.
Artigo
em Inglês
| MEDLINE | ID: mdl-29350310
13.
Processed Meat and Risk of Renal Cell and Bladder Cancers.
Nutr Cancer
; 70(3): 418-424, 2018 04.
Artigo
em Inglês
| MEDLINE | ID: mdl-29570985
14.
The outcome to axitinib or everolimus after sunitinib in metastatic renal cell carcinoma.
Anticancer Drugs
; 29(7): 705-709, 2018 08.
Artigo
em Inglês
| MEDLINE | ID: mdl-29846246
15.
Enzalutamide after chemotherapy in advanced castration-resistant prostate cancer: the Italian Named Patient Program.
Future Oncol
; 14(26): 2691-2699, 2018 Nov.
Artigo
em Inglês
| MEDLINE | ID: mdl-30207488
16.
Long-term clinical impact of PSA surge in castration-resistant prostate cancer patients treated with abiraterone.
Prostate
; 77(9): 1012-1019, 2017 Jun.
Artigo
em Inglês
| MEDLINE | ID: mdl-28429372
17.
Predictive Comprehensive Geriatric Assessment in elderly prostate cancer patients: the prospective observational scoop trial results.
Anticancer Drugs
; 28(1): 104-109, 2017 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-27579728
18.
Associations of dietary carbohydrates, glycaemic index and glycaemic load with risk of bladder cancer: a case-control study.
Br J Nutr
; 118(9): 722-729, 2017 Nov.
Artigo
em Inglês
| MEDLINE | ID: mdl-28990544
19.
ProEx C as Diagnostic Marker for Detection of Urothelial Carcinoma in Urinary Samples: A Review.
Int J Med Sci
; 14(6): 554-559, 2017.
Artigo
em Inglês
| MEDLINE | ID: mdl-28638271
20.
Long-Term Toxicity and Quality of Life in Patients Treated for Locally Advanced Cervical Cancer.
Oncology
; 90(1): 29-35, 2016.
Artigo
em Inglês
| MEDLINE | ID: mdl-26473609